1 |
Kang DH, Kim JH, Lim HW, Kim JY, Kwon K, A Case Study of Chronic Plantar Pompholyx Including Steroids Side Effects, The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology 2011;24(1):181-191.
|
2 |
Shin SH, Yun JM, Heo JE, Ko WS, Yoon HJ, A Case Study on Steroid Rebound Phenomenon after Steroids Treatment for Pompholyx. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(3):155-161.
DOI
|
3 |
Hameed AF. Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients. ISRN Dermatol [serial online] 2013 Apr 21;2013:491376. Available from: URL:http://dx.doi.org/10.1155/2013/491376.
DOI
|
4 |
Forte WCN, Sumita JM, Rodrigues AG, Liuson D, Tanaka E. Rebound phenomenon to systemic cortico- steroid in atopic dermatitis. Allergol Immunopathol (Madr). 2005;33(6): 307-11.
DOI
|
5 |
Yang MS, Kim JS, Choi JH, Jung MY, Park SY, Two Cases of Dyshidrotic Eczema Treated with Gagam-tongcheong-san, J Korean Med Ophthalmol Otolaryngol Dermatol 2016;29(4):199-205.
DOI
|
6 |
Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(5):305.
DOI
|
7 |
Veien NK. Acute and recurrent vesicular hand dermatitis. Dermatol Clin. 2009;27(3):337.
DOI
|
8 |
Jung JY, Han KH. Common Skin Diseases in Korea. Seoul: MD World, 2009.
|
9 |
Hwang MW. Lecture of Sasang Constitutional Medicine. 1st ed. Seoul:Koonja Publishing. 2012. (Korean)
|
10 |
Weon YH, Bak JY, Bak CE, Three Case of Pompholyx Treated by Sasang Medicine, J Korean Med Ophthalmol Otolaryngol Dermatol 2014;27(4):221-229.
DOI
|
11 |
E. Vocks, S.G. Plotz, J. Ringa. The Dyshidrotic Eczema Area and Severity Index - A Score Developed for the Assessment of Dyshidrotic Eczema. Dermatology 1999;198:265-269.
DOI
|
12 |
David R Adams, MD, PharmD, James G Marks, Jr, MD. (2017). Acute palmoplantar eczema (dyshidrotic eczema). https://www.uptodate.com
|